Valchlor
Payments companies reported to CMS as associated with Valchlor. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Valchlor, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Valchlor
These are the largest totals companies reported as associated with Valchlor. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Timothy Henkel | Hilton Head Island, SC | Infectious Disease | $494,172.33 |
| H Wilkins | Sellersville, PA | Family Medicine | $243,992.40 |
| William Hamilton | Gainesville, FL | Anatomic Pathology & Clinical Pathology | $83,321.59 |
| Philip Schein | Bryn Mawr, PA | Medical Oncology | $20,480.80 |
| Oleg Akilov | Pittsburgh, PA | Dermatology | $16,305.50 |
| Larisa Geskin | New York, NY | Dermatology | $11,856.11 |
| Christiane Querfeld | Duarte, CA | Dermatopathology (Dermatology) | $10,981.02 |
| Jennifer Desimone | Fairfax, VA | Dermatology | $9,871.75 |
| Ingerlisa Mattoch | Loveland, CO | Dermatopathology (Pathology) | $4,600.00 |
| Neda Nikbakht | Philadelphia, PA | Dermatology | $3,184.91 |
Prescribed Valchlor?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.